Radon inhalation suppresses nephropathy in streptozotocin-induced type-1 diabetic mice

Yuichi Nishiyama, Takahiro Kataoka, Keiko Yamato, Reo Etani, Takehito Taguchi, Kiyonori Yamaoka

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In this study, we investigated the suppressive effects of radon inhalation against nephropathy in C57BL/6J mice with type-1 diabetes induced by intraperitoneal injection of streptozotocin (50 mg/kg weight, given five times). Four weeks after diabetes induction, the diabetic mice were continuously treated with inhaled radon-222 of 2000 Bq/m3 or air only (sham) for four weeks. The results showed that radon inhalation did not affect type-1 diabetic symptoms such as body weight loss, hyperglycemia, and hypoinsulinemia. However, diabetic mice treated with radon showed lower urinary albumin excretion and fibrotic change in renal glomeruli compared with diabetic mice not treated with radon. Furthermore, renal superoxide dismutase activity and glutathione content were significantly higher in diabetic mice treated with radon than in diabetic mice not treated with radon. These findings suggested that radon inhalation enhanced renal antioxidants activities, resulting in the suppression of diabetic nephropathy. This study may contribute to the development of a novel approach in the treatment of nephropathy for diabetic patients.

Original languageEnglish
JournalJournal of Nuclear Science and Technology
DOIs
Publication statusAccepted/In press - Aug 1 2015

Fingerprint

Radon
respiration
radon
mice
Medical problems
hyperglycemia
glomerulus
body weight
excretion
glutathione
inorganic peroxides
antioxidants
Antioxidants
albumins
induction
retarding
injection
air
Air

Keywords

  • antioxidant
  • diabetic nephropathy
  • oxidative stress
  • radon
  • reactive oxygen species

ASJC Scopus subject areas

  • Nuclear and High Energy Physics
  • Nuclear Energy and Engineering

Cite this

@article{f2553d4e19fc45bb84c856b1d87f77a7,
title = "Radon inhalation suppresses nephropathy in streptozotocin-induced type-1 diabetic mice",
abstract = "In this study, we investigated the suppressive effects of radon inhalation against nephropathy in C57BL/6J mice with type-1 diabetes induced by intraperitoneal injection of streptozotocin (50 mg/kg weight, given five times). Four weeks after diabetes induction, the diabetic mice were continuously treated with inhaled radon-222 of 2000 Bq/m3 or air only (sham) for four weeks. The results showed that radon inhalation did not affect type-1 diabetic symptoms such as body weight loss, hyperglycemia, and hypoinsulinemia. However, diabetic mice treated with radon showed lower urinary albumin excretion and fibrotic change in renal glomeruli compared with diabetic mice not treated with radon. Furthermore, renal superoxide dismutase activity and glutathione content were significantly higher in diabetic mice treated with radon than in diabetic mice not treated with radon. These findings suggested that radon inhalation enhanced renal antioxidants activities, resulting in the suppression of diabetic nephropathy. This study may contribute to the development of a novel approach in the treatment of nephropathy for diabetic patients.",
keywords = "antioxidant, diabetic nephropathy, oxidative stress, radon, reactive oxygen species",
author = "Yuichi Nishiyama and Takahiro Kataoka and Keiko Yamato and Reo Etani and Takehito Taguchi and Kiyonori Yamaoka",
year = "2015",
month = "8",
day = "1",
doi = "10.1080/00223131.2015.1078751",
language = "English",
journal = "Journal of Nuclear Science and Technology",
issn = "0022-3131",
publisher = "Atomic Energy Society of Japan",

}

TY - JOUR

T1 - Radon inhalation suppresses nephropathy in streptozotocin-induced type-1 diabetic mice

AU - Nishiyama, Yuichi

AU - Kataoka, Takahiro

AU - Yamato, Keiko

AU - Etani, Reo

AU - Taguchi, Takehito

AU - Yamaoka, Kiyonori

PY - 2015/8/1

Y1 - 2015/8/1

N2 - In this study, we investigated the suppressive effects of radon inhalation against nephropathy in C57BL/6J mice with type-1 diabetes induced by intraperitoneal injection of streptozotocin (50 mg/kg weight, given five times). Four weeks after diabetes induction, the diabetic mice were continuously treated with inhaled radon-222 of 2000 Bq/m3 or air only (sham) for four weeks. The results showed that radon inhalation did not affect type-1 diabetic symptoms such as body weight loss, hyperglycemia, and hypoinsulinemia. However, diabetic mice treated with radon showed lower urinary albumin excretion and fibrotic change in renal glomeruli compared with diabetic mice not treated with radon. Furthermore, renal superoxide dismutase activity and glutathione content were significantly higher in diabetic mice treated with radon than in diabetic mice not treated with radon. These findings suggested that radon inhalation enhanced renal antioxidants activities, resulting in the suppression of diabetic nephropathy. This study may contribute to the development of a novel approach in the treatment of nephropathy for diabetic patients.

AB - In this study, we investigated the suppressive effects of radon inhalation against nephropathy in C57BL/6J mice with type-1 diabetes induced by intraperitoneal injection of streptozotocin (50 mg/kg weight, given five times). Four weeks after diabetes induction, the diabetic mice were continuously treated with inhaled radon-222 of 2000 Bq/m3 or air only (sham) for four weeks. The results showed that radon inhalation did not affect type-1 diabetic symptoms such as body weight loss, hyperglycemia, and hypoinsulinemia. However, diabetic mice treated with radon showed lower urinary albumin excretion and fibrotic change in renal glomeruli compared with diabetic mice not treated with radon. Furthermore, renal superoxide dismutase activity and glutathione content were significantly higher in diabetic mice treated with radon than in diabetic mice not treated with radon. These findings suggested that radon inhalation enhanced renal antioxidants activities, resulting in the suppression of diabetic nephropathy. This study may contribute to the development of a novel approach in the treatment of nephropathy for diabetic patients.

KW - antioxidant

KW - diabetic nephropathy

KW - oxidative stress

KW - radon

KW - reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=84940521185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940521185&partnerID=8YFLogxK

U2 - 10.1080/00223131.2015.1078751

DO - 10.1080/00223131.2015.1078751

M3 - Article

JO - Journal of Nuclear Science and Technology

JF - Journal of Nuclear Science and Technology

SN - 0022-3131

ER -